Financials
- Market Capitalization 4.57 M
- Employee 5
- Founded 2018
- CEO N/A
- Website www.ernexatx.com
- Headquarter Delaware, United States
- FIGI BBG000CX5677
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4959 | CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.62 USD | +5.19% | -3.57% | -19.40% | -38.29% | 4.79 M USD | ||
| 4961 | SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 4.40 USD | -1.35% | -9.28% | -26.17% | +547.06% | 4.77 M USD | ||
| 4971 | EVGN Evogene Ltd. - Ordinary Shares | 0.52 USD | -3.70% | -5.45% | +33.33% | -58.73% | 4.53 M USD | ||
| 4972 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 0.10 USD | -9.09% | -9.09% | -9.09% | -98.72% | 4.49 M USD |
Frequently asked questions about Ernexa Therapeutics Inc. - Common Stock
What is the Ernexa Therapeutics Inc. - Common Stock stock price today?
The current price of Ernexa Therapeutics Inc. - Common Stock (ERNA) is 3.92. Over the past 24 hours, the stock has changed by -0.25%. Follow the ERNA chart for real-time price dynamics.
What is the stock ticker of Ernexa Therapeutics Inc. - Common Stock?
Ernexa Therapeutics Inc. - Common Stock trades under the ticker ERNA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ernexa Therapeutics Inc. - Common Stock stock going up?
ERNA has changed by -24.76% over the last week, -41.14% over the last month, and +1021.60% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ernexa Therapeutics Inc. - Common Stock net income for the last quarter?
Ernexa Therapeutics Inc. - Common Stock reported net income of -5.51 M for the last quarter. The previous quarter showed -1.5 M, which means net income changed by -266.33%.
How many employees does Ernexa Therapeutics Inc. - Common Stock have?
As of the latest available data, Ernexa Therapeutics Inc. - Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ernexa Therapeutics Inc. - Common Stock EBITDA?
Ernexa Therapeutics Inc. - Common Stock EBITDA is -5.57 M, and its EBITDA margin is -39.77 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ernexa Therapeutics Inc. - Common Stock stock?
You can buy Ernexa Therapeutics Inc. - Common Stock (ERNA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ernexa Therapeutics Inc. - Common Stock stock?
Investing in Ernexa Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ERNA chart and related analysis on metatrader.com as part of your research.